about
ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescentsDistinct genetic risk based on association of MET in families with co-occurring autism and gastrointestinal conditionsTreatment of attention-deficit/hyperactivity disorder: overview of the evidenceA new definition of children with special health care needsA review of the evidence for the medical home for children with special health care needsRacial and ethnic differences in subspecialty service use by children with autism.Performance profiles: the influence of patient satisfaction data on physicians' practice.Healthcare for children with autism: the Autism Treatment Network.A report card on quality improvement for children's health care.Variations in rates of hospitalization of children in three urban communities.Health services research for children with disabilities.Measuring quality of life in pediatric patients with inflammatory bowel disease: psychometric and clinical characteristics.The Food and Drug Administration's deliberations on antidepressant use in pediatric patients.Adolescents' use of the built environment for physical activityOptimism and the socioeconomic status gradient in adolescent adiposityPoint-of-Care Child Psychiatry Expertise: The Massachusetts Child Psychiatry Access Project.Use of clinical preventive services in infants, children, and adolescentsTrends in attention deficit hyperactivity disorder ambulatory diagnosis and medical treatment in the United States, 2000-2010.Impact of type 1 diabetes mellitus on the family is reduced with the medical home, care coordination, and family-centered careIn the Aftermath of the National Children's Study.Provision of fluoride varnish to Medicaid-enrolled children by physicians: the Massachusetts experience.Outpatient Visits and Medication Prescribing for US Children With Mental Health Conditions.Adverse drug events in pediatric outpatients.A family-centered, community-based system of services for children and youth with special health care needs.Impact of false-positive newborn metabolic screening results on early health care utilization.The future of health insurance for children with special health care needs.Systematic evidence review of newborn screening and treatment of severe combined immunodeficiency.Weighing the evidence for newborn screening for early-infantile Krabbe disease.Weighing the evidence for newborn screening for Hemoglobin H disease.Evidence for family-centered care for children with special health care needs: a systematic review.Cardiovascular risk of stimulant treatment in pediatric attention-deficit/hyperactivity disorder: update and clinical recommendations.Psychological aspects of chronic health conditions.Health care transition for youth with special health care needs.Pediatric Accountable Care Organizations: Insight From Early Adopters.Fully Capitated Payment Breakeven Rate for a Mid-Size Pediatric Practice.The Autism Treatment Network and Autism Intervention Research Network on Physical Health: future directions.Social influences on health-risk behaviors among minority middle school students.Who cares for medicaid-enrolled children with chronic conditions?Supplemental Security Income Benefits for Mental Disorders.A Multimodal Counseling-Based Adolescent Physical Activity Intervention.
P50
Q22241496-3B10BFCF-A1BD-492C-B96B-A25C85AAD2E4Q28236917-D2D358D7-FDFA-4070-A885-E41F33E153CFQ28254103-5E13FA98-46B0-4002-863D-4FBCA10DDFD3Q28280374-5F0B7F9F-8DC8-40D9-94E8-BF26C61CC136Q28295750-A77B30DC-5B6F-454F-B8AF-9470A1F3E0C2Q30649934-085F800B-B9A9-46E2-B8F2-9354CDB4D78DQ30690554-961A6596-620C-4C6F-B514-02345A9D9E51Q33501991-47EFF562-A644-4487-B3E7-F02F6794F533Q34116449-34BFB079-01AC-4123-B0C2-E934F7A343A3Q34523032-B1F81BBC-B1D5-4487-AACB-B8D87AD7CEF0Q34724647-CC2800AF-AEAA-46D8-99F0-B92F8DD5F9BFQ34727793-C153AB80-D9AD-44E4-BFC7-06D2D5E7684EQ34998784-ED8FD101-D52B-43C0-BCD1-AF02F3D0DBB5Q35205189-4BE9C434-574A-450A-90F9-48F057E7BBEBQ35451914-EC5D5375-DCE2-4FBF-A497-17250CB52F66Q35544742-FEF3BF94-FF94-4676-AC45-A7207FA9AB13Q35601638-9F7BDAC7-7F9F-4E98-8869-5338CE2513AEQ35840321-471AB877-C384-44B6-AF12-B91DE2ABBA3FQ35894856-893DD35B-1785-446A-8043-18BB384D251FQ36035159-41BB9ABF-85F6-4CA8-B7B0-B65968D6E679Q36085512-8745DB29-B4F0-410B-85BD-87ADE02C199CQ36210570-70279526-C1D0-45B0-8D22-C8BE1FBFCCB2Q36942939-91013E1A-28FB-4E2F-8F83-A986B847D303Q36957278-57091241-970B-4506-97F5-35908123950DQ37411500-ADC1393D-FBA6-4BD9-A34B-F656F07F183BQ37464462-A40E4F0A-C107-42B6-99B2-8453C98C3AB6Q37733960-BED8700F-5495-4EF2-817E-713032293930Q37770047-9DCD2EBA-9D42-4C49-98D9-62945DB004B2Q37822035-C0F2A53D-8BC6-4558-9E67-13B6A62EF16BQ37852234-1E5D08E7-1203-4D03-8DFC-045303F7796BQ37941074-6D693F7A-96D5-4718-9A17-5F8324519F6FQ37989906-DD072EAD-72F3-44E9-8EC0-6B438EFCD1E6Q38037802-2226016C-BEF3-43F3-B24D-2B944D9A24C1Q38763585-D145A021-E9B9-4D80-83AD-9B213E9BB49DQ38913022-9D2B90BD-6FE1-472A-8ACA-644C41AB0DC9Q39523893-922DA833-6DBC-4996-A45C-DE1DF2BD6FAAQ39568694-F24E0ADD-6FDE-4535-91F5-955F18571EB5Q39581110-717041CB-7F1D-4E22-83B6-A7E43E5EDBDDQ39697797-5C315EAD-0CE0-4087-B10D-884AFDCE1C17Q39729559-60F8E6A4-9BCD-4955-A7D4-26E2F5A4472C
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
James M Perrin
@nl
James M Perrin
@sl
James M. Perrin
@en
James M. Perrin
@es
type
label
James M Perrin
@nl
James M Perrin
@sl
James M. Perrin
@en
James M. Perrin
@es
prefLabel
James M Perrin
@nl
James M Perrin
@sl
James M. Perrin
@en
James M. Perrin
@es
P106
P1153
7201748742
P21
P31
P496
0000-0002-1810-3708